Sigma-Aldrich Bid for Thermo

/by

One of Life’s main competitors in the life science reagent market, Sigma has a smaller market capital and annual revenues than Life. The purchase would have enabled Sigma to compete more effectively with Thermo in terms of scale and product breadth.

New York, NY 4/16/13—Bloomberg reported that Sigma-Aldrich was among the bidders for Life Technologies (see IBO 4/15/13), offering around $12.5 billion for the company. Sigma planned to sell the sequencer business if it acquired Life in order to help fund the transaction, according to the report. Sigma held talks with Roche and Agilent Technologies regarding the sequencer business.

< | >